Navigation Links
Heart Defect Is Linked to Some Cases of Migraine Headache

A severe migraine attack can be agonizingly painful and accompanied by extreme light sensitivity and powerful nausea. Medications control some people's headaches, but// for some sufferers no drug completely prevents debilitating attacks.

For such people, hope may come from a new clinical trial, conducted in part at Washington University School of Medicine in St. Louis. The trial offers an unexpected solution — doctors are closing a hole in the heart to try to fix the ache in the head.

About 600 million people around the world, including some 28 million Americans, get migraine headaches. Physicians and researchers suspect a link between migraines and a particular heart defect in some people.

The defect is called a patent foramen ovale or PFO. A remnant of fetal development, a PFO is a hole between the two upper chambers of the heart and is generally smaller than a pencil eraser. In about 25 percent of people, the hole stays partially open after birth, leaving a PFO, a tiny, flap-covered passage between the atria.

“A PFO serves as a strain valve,” explains John M. Lasala, M.D., Ph.D., who oversees the Washington University portion of the migraine/PFO study. “If the pressure gets too high on the right side of the heart, the PFO can open, and blood can travel from the right to the left side. We think something usually cleared out by the lungs is in that blood and can trigger migraines.”

Estimates now hold that PFOs are present in about half of migraine sufferers who experience aura — an arc of zigzag lines in the visual field, numbness of one side of the face, weakness or altered consciousness — and in about a quarter of those who don’t have aura with their migraines.

Early results from a set of ongoing British clinical trials of PFO closure in migraine patients found a 37 percent reduction in migraine frequency and duration. Now the Washington University School of Medicine is one of 13 centers cond
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:
(Date:7/25/2008)...o benefit ALS Therapy Alliance to be presented at ..., WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/p...ed a record-breaking $4.4 million in just 21 days,...or ALS research. This is,the seventh year of the a...d more than $15 million for ALS research. This yea...
(Date:7/25/2008)... fluid back-up in esophagus can cause immune syste... News) -- The first evidence linking gastroesophag...overed by Duke University Medical Center researche... was first noted in the 1970s, and since then stud...ent of asthma patients also experience GERD sympto...
(Date:7/25/2008)... New program delivers immediate cost...4-hour telephone access to language interpreters] ...multilingual solutions. , ...E® http://www.lle-inc.com/index.html [(Langu...er of interpretation, translation, and language in...
(Date:7/25/2008)... Whether you are an Olympian, Profes...there are Five Things You Need to Know about Hydra.... Spine and Sports Center , ... America,s premier athletes are heading to Beijing... and sacrifice in the hopes of capturing an Olympi...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...ak at mathematics, reading, and writing better wat...ds, for a research suggests that such symptoms may... than their peers. Authored by Alyssa Bachmann of ...as focused on the parents of 218 second and third ...
...zard mothers dress their children in different col...onditions that the babies will face as adults . R...Cruz, have found that female side-blotched lizards...r patterns in their broods in response to social c...
...esearchers in National Institutes of Health, an in...ementia increases with the number of different dis... findings is the observation that the combination ...rcts (strokes) is the most common mix of pathologi...
... is under immense pressure trying to survive amid ...or help from a woman dying in the emergency room o...d to have been ignored by the in house staff. Lik...too was rejected by the dispatchers, ultimately le...
Other Medicine News:Health News:Students With Sleep Disorder Symptoms Score Badly in Maths 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 3Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:Womans Death increases Pressure on LA Hospital to close down 2
(Date:7/23/2008)...CISCO, July 23 /- InCode BioPharmaceu... today announced preclinical test,results demonstr...-1 for,the treatment of the rare chronic blood dis...he complete results will be presented at the XXII,...rland, September 28,2008., The only treatment cu...
(Date:7/22/2008)... efficacy results from a multi-center 293-patient ...oronto Stock Exchange Symbol: CYT, MONTREAL, July...ies,Inc., the global leader in cryotherapy product...at results previously presented from three,Europea...Arctic Front(R),were published earlier today in t...
(Date:7/22/2008)...onstrates Feasibility and Efficacy of Treating Pat...Cancer, SAN FRANCISCO, and YONGIN-SI, South Korea...cisco, CA and Ottawa, Ontario), and its South,Kore... novel findings from,a Phase I clinical trial of i... that the product was well-tolerated and resulted ...
(Date:7/22/2008)...N FRANCISCO, Calif., July 22 /- Hyper... completed patient enrollment,in its Phase 1/2 cli...nd,ammonia scavenging effects of HPN-100 (formally...yrate) in patients with urea cycle disorders,(UCD)...n the fourth quarter,of this year., (Logo: http:...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Speaker judges set for Global Venture Challenge 2483 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 2STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 1Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 2Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 4Killer fungus spells disaster for wheat 2480 1Killer fungus spells disaster for wheat 2480 2Killer fungus spells disaster for wheat 2480 3
...Md., March 29, 2007--For depressed people with bip...ding an antidepressant,medication is no more effec...ults published online on March 28, 2007 in the New... of the,large-scale, multi-site Systematic Treatme...BD), a $26.8 million clinical trial,funded by the ...
...lar Ultrasound Demonstrates Utility in Evaluating ...ous Potential for HDL,Therapy , ,PLEASANTON, CA, M...-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. Brya...Sciences, Inc., concluded from,the wide range of p...diology (ACC) Meeting in New Orleans that the rati...
Other Medicine Technology:Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 2Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
Selecta Trio The pinnacle in the family, combining the Nd:YAG, diode-pumped solid-state (DPSS) 532 Photocoagulator and Q-switched frequency-doubled 532nm laser (SLT) and offering maximum flexibility
Ultimum hemostasis introducers provide outstanding insertion performance, with excellent wire-to-dilator and dilator-to-sheath transitions, high kink resistance and minimal wall thickness. A dual lay
... Haemonetics' latest multi-component platform, whi...the collection of platelets, red cells, plasma, an... possibilities for therapeutic apheresis procedure...llection organizations throughout the world to imp...
The PCS2 system is Haemonetics latest technology for the collection of plasma and flexible protocols allow for the collection of "jumbo" units of platelet-poor plasma, platelet-poor plasma with optio
Medicine Products: